Aviv Regev: The Computational Biologist Remaking Drug Discovery At Genentech

 
• By David Wild
  
Aviv Regev, head of Early Research and Development, Genentech
Aviv Regev, head of Early Research and Development, Genentech (Genentech)

More from C-Suite Speaks

More from Leadership